Crisnatol

Add links
Source: Wikipedia, the free encyclopedia.
Crisnatol
Clinical data
ATC code
  • none
Identifiers
  • 2-(Chrysen-6-ylmethylamino)-2-methylpropane-1,3-diol
JSmol)
  • CC(CO)(CO)NCc1cc2c3ccccc3ccc2c4c1cccc4
  • InChI=InChI=1S/C23H23NO2/c1-23(14-25,15-26)24-13-17-12-22-18-7-3-2-6-16(18)10-11-21(22)20-9-5-4-8-19(17)20/h2-12,24-26H,13-15H2,1H3 checkY
  • Key:SBRXTSOCZITGQG-UHFFFAOYSA-N checkY

Crisnatol (BW-A770U) is an experimental

anticancer agent.[1] A Phase I clinical trial was published in 1999.[2]

References

  1. ^ U.S. patent 4,719,046
  2. PMID 10589747
    .
drug article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Crisnatol&oldid=1120069100"